A pharmacometrics model to define docetaxel target in early breast cancer
Aims: We aimed to study the relation between pharmacokinetics (PK) and pharmacodynamics (PD) of docetaxel in early breast cancer and recommend a target exposure. Methods: A PK/PD study was performed in 27 early breast cancer patients treated with doxorubicin and cyclophosphamide for 4 cycles foll...
| Hlavní autoři: | , , |
|---|---|
| Médium: | info:eu-repo/semantics/article |
| Jazyk: | eng |
| Vydáno: |
Wiley
2023
|
| Témata: | |
| On-line přístup: | https://hdl.handle.net/10171/66083 |